Introduction: Determine the prevalence and associated factors of diabetic retinopathy (DR) among people with type 2 diabetes. Design: Cross-sectional study Methods: We obtained data of people with type 2 diabetes retrospectively from a community-based DR screening database in Greater Bandung, Indonesia. We encoded the two fields mydriatic 45-degree fundus images to estimate prevalence. The associated factors analysis used multivariate logistic regression. Results: We screened a total of 4,251 people with type 2 diabetes from January 2016 to December 2019. The overall age-standardised prevalence of any DR was 30.7% (95% CI: 28.7%-32.8%) and vision-threatening DR 7.6% (95% CI: 6.5%-9.0%). The following factors were associated with a higher prevalence of any DR: ages 50+ (OR:1.37;  95% CI:1.05-1.77), duration of diabetes five to ten years (OR:1.38; 95% CI:1.11-1.71) and more than ten years (OR:1.40; 95% CI:1.13-1.73), and postprandial blood glucose 200 mg/dl and higher (OR:1.27; 95% CI:1.03-1.52). The following factors were associated with a higher prevalence of vision-threatening DR: duration of diabetes five to ten years (OR:2.01; 95% CI:1.39-2.91) and more than ten years (OR:1.86; 95% CI:1.28-2.71), postprandial blood glucose 200 mg/dl or higher (OR:1.52; 95% CI:1.05-2.21) and systolic blood pressure 180 mmHg or higher (OR:2.67; 95% CI:1.16-6.17). Conclusion: Diabetic retinopathy is prevalent among people with type 2 diabetes. People with diabetes should regulate their blood glucose and blood pressure to prevent retinopathy related vision loss.

Lacrimal drainage obstruction is a common disorder of lacrimal system. This obstruction could affect lacrimal punctum, canaliculi, lacrimal sac, and lacrimal duct. The etiology could be congenital or acquired, such as triggered by infection or other conditions. This case series illustrates the procedure of canaliculotomy to reduce the epiphora symptom caused by lacrimal drainage obstruction, specifically in punctum and canaliculi. The aim of this case series was to report the management of punctal and canaliculi obstruction with canaliculotomy procedure. Case 1, an eighty-two years old woman with chronic canaliculitis on the right eye due to Actynomyces sp. infection, underwent canaliculotomy and curetage of canalicular area of the right eye. Case 2, a sixty-years old man with chronic canaliculitis with canalicular fistula on the left eye underwent canaliculotomy with silicone tube procedure on the left eye. Case 3, a sixty-seven years old man with recurrent punctal obstruction due to punctal stenosis of the left eye, previous punctoplasty, underwent canaliculotomy with silicone tube. Identification of the patient's symptoms is very important in determining the diagnosis and management plan for the patient. Canaliculotomy procedure with antimicrobial and steroid medication after procedure leads to a good result in reducing symptoms caused by lacrimal drainage obstruction due to various etiology.

Background: Obstructive Meibomian gland dysfunction (MGD) leads to a decreased availability ofmeibomian lipid at the ocular surface that could result in ocular surface damage due to increasedevaporation of the aqueos layer of the tear film. Alteration of meibomian oil (meibum) is one of thecausative factors of the obstructive process and the sign of the obstruction as well.Methods: This was a cross-sectional study using Spearman’s Rank Correlation Coeeficient (rs) to findcorrelation between meibum quality and the ocular surface damage. Subjects were patients withobstructive MGD selected consecutively in Infection and Immunology Unit of Indonesia National EyeCenter, Cicendo Eye Hospital. There were 48 eyes from 29 subjects comprised 28 inflamed MGD and20 non-inflamed MGD. Meibum quality was assessed by performing digital expression on eightmeibomian glands located on the lower lid. Ocular surface damage was done by performing cornealstaining using fluorescein eye drop and conjunctival staining using Lissamine Green strip. The stainingresults were then documented using camera of slit lamp biomicroscopy and based on the documentation,scoring of the ocular surface staining was done using National Eye Institute/Industry (NEI)scheme/diagram.Results: This study showed no correlation (rs: -0.067) between meibum quality and ocular surfacedamage (p=0.652). Statistical analysis was also done on subjects categorized based on inflammationon the eyelid and there was found correlation (rs: 0.238) between meibum quality and ocular surfacedamage in inflamed MGD (p=0.312).Conclusion: There is no correlation between the quality of meibum and ocular surface staining.Keywords: obstructive MGD, quality of meibum, ocular surface damage

Background: Intravitreal bevacizumab (IVB) appears to be an effective and safe drug for reducing macular edema and improving visual acuity secondary to RVO. Grid photocoagulation to macular edema caused by BRVO significantly improved long-term visual prognosis. In CRVO, reduced the angiographic evidence of macular edema, but did not lead to improvement in the vision of treated eyes. Methods: an observational, retrospective study from medical record of patients RVO underwent IVB and combined treatment at Cicendo National Eye Center conducted between January and December 2012. A total of 49 eyes from 49 patients met the inclusion criteria. Data was compiled on demographic characteristics, pre and postoperative visual acuities. The main outcome was proportion of visual gain in 1 month after therapy. Result: All patients (49 eyes) completed the 1 months follow-up with 17 patients BRVO who had treatment IVB and 11 patients with combined treatment. And 14 patients CRVO who had treatment IVB and 7 patients had combined treatment. The proportion of BRVO and CRVO eyes have the same visual improvement in IVB and combined treatment groups (BRVO 58.8% vs 72.7%, p=0.120 and CRVO 57.1% vs 57.1%, p=1.000). Conclusion: There was no significant difference in the proportion of visual improvement between IVB and combined treatment groups in BRVO and CRVO at one months follow up. Keywords: branch retinal vein occlusion, central retinal vein occlusion, intravitreal bevacizumab, laser photocoagulation